DNA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 17:38):

Stats
Dagens volum	48.28M
Gjennomsnittsvolum	26.69M
Markedsverdi	2.13B
EPS	$0 ( 2024-02-29 )
Neste inntjeningsdato	( $-0.0800 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.15
ATR14	$0.0140 (1.41%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Dmytruk Mark E.	Sell	22 916	Restricted Stock Units
2024-04-01	Dmytruk Mark E.	Buy	1 634	Class A Common Stock
2024-04-01	Dmytruk Mark E.	Buy	22 916	Class A Common Stock
2024-04-01	Dmytruk Mark E.	Buy	18 125	Class A Common Stock
2024-04-01	Dmytruk Mark E.	Buy	65 448	Class A Common Stock

INSIDER POWER
-25.19
Last 100 transactions
Buy: 2 333 675 \| Sell: 4 285 014

Volum Korrelasjon

Lang: 0.23 (neutral)

Kort: -0.03 (neutral)

Signal:(29.313) Neutral

Ginkgo Bioworks Holdings, Korrelasjon

10 Mest positive korrelasjoner
ATTO	0.927
KT	0.92
DHX	0.918
ARMK	0.912
WF	0.911
PDS	0.911
WRBY	0.902
MYTE	0.902
AVYA	0.899
AMRC	0.899

10 Mest negative korrelasjoner
RXN	-0.884
MOG-B	-0.881
DSE	-0.872
COR	-0.872
MSP	-0.87
PSXP	-0.868
AMAM	-0.864
TNK	-0.855
CMO	-0.851
FPAC	-0.851

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Ginkgo Bioworks Holdings, Korrelasjon - Valuta/Råvare

0.25
( neutral )

-0.06
( neutral )

0.00
( neutral )

-0.21
( neutral )

0.00
( neutral )

0.51
( weak )

Ginkgo Bioworks Holdings, Økonomi

Annual	2023
Omsetning:	$251.46M
Bruttogevinst:	$142.64M (56.73 %)
EPS:	$-0.460

FY	2023
Omsetning:	$251.46M
Bruttogevinst:	$142.64M (56.73 %)
EPS:	$-0.460

FY	2022
Omsetning:	$477.71M
Bruttogevinst:	$273.49M (57.25 %)
EPS:	$-1.250

FY	2021
Omsetning:	$313.84M
Bruttogevinst:	$204.16M (65.05 %)
EPS:	$-1.231

Financial Reports:

No articles found.

Ginkgo Bioworks Holdings,

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.